Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes
NCT01192425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5580
Last updated 2010-09-01
Summary
Examine red and white blood cells of PNH patients with bone marrow failure syndromes.
Conditions
- Hemoglobinuria
Sponsors & Collaborators
-
Alexion Pharmaceuticals, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in China
NCT05125341 ·Status: COMPLETED
-
Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease
NCT05565092 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT06050226 ·Status: COMPLETED ·Phase: PHASE2
-
Global PNH Patient Registry
NCT05755867 ·Status: RECRUITING
-
Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia
NCT01362595 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of LNP023 in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT03439839 ·Status: COMPLETED ·Phase: PHASE2
-
Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
NCT01294891 ·Status: COMPLETED
-
A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome
NCT00095264 ·Status: COMPLETED ·Phase: PHASE2
-
Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events
NCT02539771 ·Status: COMPLETED ·Phase: NA
-
A Phase II Trial of Regadenoson in Sickle Cell Anemia
NCT01788631 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Global Coagulation Tests in Patients With Paroxysmal Nocturnal Haemoglobinuria
NCT01020188 ·Status: COMPLETED
-
Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)
NCT03263559 ·Status: COMPLETED ·Phase: PHASE2
-
Spectrum of Hematological Disorders in Pediatrics
NCT05473650 ·Status: UNKNOWN
-
Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT06933914 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT00039923 ·Status: COMPLETED
-
Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy
NCT01956799 ·Status: COMPLETED
-
AB1 in Adult Patients with Sickle Cell Disease (SCD)
NCT05261711 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome
NCT01310959 ·Status: UNKNOWN
-
Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
NCT04128943 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria（PNH）
NCT06561841 ·Status: COMPLETED ·Phase: PHASE2
-
Medical Treatment for Diamond Blackfan Anemia
NCT00001749 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess SLN124 in Patients With Polycythemia Vera
NCT05499013 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)
NCT00000586 ·Status: COMPLETED ·Phase: PHASE3
-
Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization.
NCT03111589 ·Status: COMPLETED ·Phase: NA
-
Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data
NCT00005307 ·Status: COMPLETED